Table 2 Comparisons of EZH2 expression among different clinicopathologic characteristics of urothelial carcinoma following surgical treatment.

From: Increased expression of EZH2 indicates aggressive potential of urothelial carcinoma of the bladder in a Chinese population

 

EZH2 high n (%)

EZH2 low n (%)

*p

Sex

  Male

120 (77.4)

35 (22.6)

0.628

  Female

25 (73.5)

9 (26.5)

Age

  >60 year

95 (76.6)

29 (23.4)

0.962

  ≤60 year

50 (76.9)

15 (23.1)

Smoking history

  Smoker

60 (75.9)

19 (24.1)

0.832

  Nonsmoker

85 (77.3)

25 (22.7)

Tumor grade

  Low grade

107 (71.3)

43 (28.7)

0.001

  High grade

38 (97.4)

1 (2.6)

Pathologic stage

  MIBC

102 (81.6)

23 (18.4)

0.027

  NMIBC

43 (67.2)

21 (32.8)

Lymph nodal status

  Positive

22 (100.0)

0 (0.0)

0.018

  Negative

90 (78.9)

24 (21.1)

  1. MIBC: muscle invasive bladder cancer; NMIBC: non-muscle invasive bladder cancer
  2. * Mann–Whitney test.
Back to article page